Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Medifast (MED) Tax Provisions (2016 - 2025)

Historic Tax Provisions for Medifast (MED) over the last 16 years, with Q4 2025 value amounting to $11.7 million.

  • Medifast's Tax Provisions rose 235460.25% to $11.7 million in Q4 2025 from the same period last year, while for Dec 2025 it was $13.0 million, marking a year-over-year increase of 65466.13%. This contributed to the annual value of $13.0 million for FY2025, which is 66664.71% up from last year.
  • Per Medifast's latest filing, its Tax Provisions stood at $11.7 million for Q4 2025, which was up 235460.25% from -$400000.0 recorded in Q3 2025.
  • Medifast's 5-year Tax Provisions high stood at $14.4 million for Q2 2021, and its period low was -$2.5 million during Q2 2024.
  • For the 5-year period, Medifast's Tax Provisions averaged around $6.8 million, with its median value being $7.4 million (2022).
  • Within the past 5 years, the most significant YoY rise in Medifast's Tax Provisions was 235460.25% (2025), while the steepest drop was 18908.69% (2025).
  • Quarter analysis of 5 years shows Medifast's Tax Provisions stood at $12.7 million in 2021, then crashed by 53.72% to $5.9 million in 2022, then crashed by 36.04% to $3.8 million in 2023, then tumbled by 87.31% to $478000.0 in 2024, then surged by 2354.6% to $11.7 million in 2025.
  • Its Tax Provisions stands at $11.7 million for Q4 2025, versus -$400000.0 for Q3 2025 and $400000.0 for Q2 2025.